How M.D. was paid
$13.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Other | Total |
|---|---|---|---|---|---|---|
| Vlad Coric, M.D.Chief Executive Officer and Chairman of the Board of Directors | $920,400 | $460,200 | $2,202,480 | $9,900,043 | $17,315 | $13,500,438 |
| Matthew ButenChief Financial Officer | $596,232 | $238,493 | $656,880 | $3,001,762 | $23,885 | $4,517,252 |
| Kimberly GentileSenior Vice President, Clinical Operations | $508,879 | $228,996 | $579,600 | $2,626,542 | $19,847 | $3,963,864 |
| Bruce Car, Ph.D.Chief Scientific Officer | $536,190 | $241,286 | $734,160 | $3,232,667 | $23,885 | $4,768,188 |
What changed and why
- $13.5MCEO total compensation increased to $13,500,438 in 2025 from $10,479,038 in 2024.
- $460KDiscretionary annual cash bonus paid to the CEO was $460,200.
- Stock and option awards represented the largest portion of executive compensation.
- $14,000All named executive officers received company 401(k) contributions of $14,000 each.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.